蛋白质工程市场 - 增长、趋势、COVID-19 影响和预测(2022 - 2027 年)

蛋白质工程市场按产品类型(胰岛素、单克隆抗体、凝血因子(血液因子 + 组织纤溶酶原)、疫苗、生长因子(激素 + 细胞因子)和其他产品类型)、技术(不合理的蛋白质设计和合理的蛋白质设计)细分)、最终用户(制药和生物技术公司、学术机构和合同研究组织 (CRO))和地理(北美、欧洲、亚太地区、中东和非洲以及南美)。

蛋白质工程市场快照

Protein Engineering Market
Study Period: 2018 - 2026
Base Year: 2021
Fastest Growing Market: Asia Pacific
Largest Market: North America
CAGR: 15.6 %

Need a report that reflects how COVID-19 has impacted this market and its growth?

市场概况

全球蛋白质工程市场增长的推动因素包括蛋白质缺乏疾病的日益流行、蛋白质药物的采用率超过非蛋白质药物、对化学工艺替代品的需求增加以及政府对蛋白质工程的资助增加.

新兴经济体农村地区的蛋白质能量营养不良 (PEM) 正在增加。它指的是一组疾病,包括消瘦、夸希奥克和消瘦-夸希奥克的中间状态。因此,kwashiorkor 的流行程度因地区而异。这在美国很少见。然而,一些受影响的地区包括东南亚、中美洲、刚果、波多黎各、牙买加和南非。因此,蛋白质缺乏疾病的日益流行正在推动对整个市场的需求。

越来越多的政府举措,例如为蛋白质工程和意识计划的研发提供资金,这些举措影响了医疗保健行业。因此,政府正在积极投资于许多研究。例如,Protein Technologies Ltd (PTL) 获得了英国政府技术战略委员会(现为 Innovate UK)的资助,用于其在蛋白质工程方面的创新研究。因此,越来越多的政府对高效蛋白质工程研究的举措有助于推动市场的整体增长。

蛋白质工程在农业化学工业中也拥有巨大的机会,因为蛋白质工程可能导致产生具有改进功能的酶,这可能会增加作物产量或促进生物燃料的生产。它还可能作为一种工具发挥重要作用,以增加满足未来需求所需的作物产量。

报告范围

根据报告的范围,蛋白质工程是对蛋白质结构的操纵以产生所需的特性,或合成具有特定结构的蛋白质。这是一个开发具有所需特性的新型蛋白质的过程,并且自过去三年以来它已经取得了巨大的发展。在过去的几年里,蛋白质工程师已经成功地生成了针对特定健康、工业、医学、研究和生物技术应用量身定制的各种蛋白质。

By Product Type
Insulin
Monoclonal Antibodies
Coagulation Factors (Blood Factors + Tissue Plasminogen)
Vaccines
Growth Factors (Hormones + Cytokine)
Other Product Types
By Technology
Irrational Protein Design
Rational Protein Design
By End User
Pharmaceutical and Biotechnology Companies
Academic Institutions
Contract Research Organizations (CROs)
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle-East and Africa
GCC
South Africa
Rest of Middle-East and Africa
South America
Brazil
Argentina
Rest of South America

Report scope can be customized per your requirements. Click here.

主要市场趋势

在预测期内,按蛋白质类型划分的单克隆抗体有望成为市场的最大贡献者

由于单克隆抗体在癌症和自身免疫性疾病等众多疗法中的广泛应用,预计单克隆抗体将在预测期内占据最大的市场份额。癌症和其他自身免疫性疾病的日益流行显着增加了单克隆抗体在疾病治疗中的应用。它们在治疗、诊断和靶向给药系统领域也有巨大的应用,用于治疗由病毒、细菌、原生动物、代谢和激素紊乱引起的传染病。因此,重组脱氧核糖核酸技术通过基因工程成功地带来了重建单克隆抗体的可能性,进而推动了该领域的增长。

Protein Engineering Market

亚太地区增长最快,预计在预测期内将遵循相同趋势

由于合同研究组织的增加、医疗保健 IT 支出的增加以及该地区医疗保健基础设施和标准的空前发展,预计亚太地区将在预测期内见证最快的复合年增长率。对个性化医疗的需求不断增长,以及对基于蛋白质组学的药物发现项目的大力研发投资,也在补充蛋白质工程市场的增长。

Protein Engineering Market- Growth Rate by Region

竞争格局

蛋白质工程市场参与者高度关注并购、新产品开发计划和地域扩张等战略。由于研发成本高且需要高端基础设施,大多数制药和生物技术公司正在转向 CRO。CRO行业的大多数参与者都在联手,以创造市场地位。

Table of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Deliverables

    2. 1.2 Study Assumptions

    3. 1.3 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Increasing Prevalence of Protein-deficient Diseases

      2. 4.2.2 Increased Demand for Alternatives to Chemical Processes

      3. 4.2.3 Increase in Adoption of Protein Drugs over Non-protein Drugs

      4. 4.2.4 Rising Government Funding for Protein Engineering

    3. 4.3 Market Restraints

      1. 4.3.1 Lack of Experts to Strategize the Process

      2. 4.3.2 High Costs

    4. 4.4 Porter's Five Forces Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION

    1. 5.1 By Product Type

      1. 5.1.1 Insulin

      2. 5.1.2 Monoclonal Antibodies

      3. 5.1.3 Coagulation Factors (Blood Factors + Tissue Plasminogen)

      4. 5.1.4 Vaccines

      5. 5.1.5 Growth Factors (Hormones + Cytokine)

      6. 5.1.6 Other Product Types

    2. 5.2 By Technology

      1. 5.2.1 Irrational Protein Design

      2. 5.2.2 Rational Protein Design

    3. 5.3 By End User

      1. 5.3.1 Pharmaceutical and Biotechnology Companies

      2. 5.3.2 Academic Institutions

      3. 5.3.3 Contract Research Organizations (CROs)

    4. 5.4 Geography

      1. 5.4.1 North America

        1. 5.4.1.1 United States

        2. 5.4.1.2 Canada

        3. 5.4.1.3 Mexico

      2. 5.4.2 Europe

        1. 5.4.2.1 Germany

        2. 5.4.2.2 United Kingdom

        3. 5.4.2.3 France

        4. 5.4.2.4 Italy

        5. 5.4.2.5 Spain

        6. 5.4.2.6 Rest of Europe

      3. 5.4.3 Asia-Pacific

        1. 5.4.3.1 China

        2. 5.4.3.2 Japan

        3. 5.4.3.3 India

        4. 5.4.3.4 Australia

        5. 5.4.3.5 South Korea

        6. 5.4.3.6 Rest of Asia-Pacific

      4. 5.4.4 Middle-East and Africa

        1. 5.4.4.1 GCC

        2. 5.4.4.2 South Africa

        3. 5.4.4.3 Rest of Middle-East and Africa

      5. 5.4.5 South America

        1. 5.4.5.1 Brazil

        2. 5.4.5.2 Argentina

        3. 5.4.5.3 Rest of South America

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Company Profiles

      1. 6.1.1 Agilent Technologies Inc.

      2. 6.1.2 Amgen Inc.

      3. 6.1.3 Bruker Corporation

      4. 6.1.4 Bio-Rad Laboratories Inc.

      5. 6.1.5 Eli Lilly and Company

      6. 6.1.6 Merck KGaA

      7. 6.1.7 Novo Nordisk AS

      8. 6.1.8 PerkinElmer Inc.

      9. 6.1.9 Thermo Fisher Scientific Inc.

      10. 6.1.10 Waters Corporation

    2. *List Not Exhaustive
  7. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The Protein Engineering Market market is studied from 2018 - 2026.

The Protein Engineering Market is growing at a CAGR of 15.6% over the next 5 years.

Asia Pacific is growing at the highest CAGR over 2021- 2026.

North America holds highest share in 2021.

Amgen Inc., Bruker Corporation, Bio-Rad Laboratories Inc., Agilent Technologies Inc., Eli Lilly and Company are the major companies operating in Protein Engineering Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!